Persones / Equip Humà

Antoni Noguera Julián

Buscador de publicacions

Publicacions

  • Fortuny-Guasch C, Deyà Á, Chiappini E, Galli L, De Martino M and Noguera-Julián A.

    Metabolic and Renal Adverse Effects of Antiretroviral Therapy in HIV-infected Children and Adolescents

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 34(5): 36-43. Nº de cites: 43

    [doi:10.1097/INF.0000000000000663]

  • Falcon-Neyra L, Benmarzouk-Hidalgo OJ, Madrid L, Noguera-Julián A, Fortuny-Guasch C, Neth O and López-Cortés L.

    No Differences of Immune Activation and Microbial Translocation Among HIV-infected Children Receiving Combined Antiretroviral Therapy or Protease Inhibitor Monotherapy

    Medicine . 94(11): . Nº de cites: 4

    [doi:10.1097/MD.0000000000000521]

  • Noyola DE, Alarcon A, Noguera-Julián A, Muntasell A, Munoz-Almagro C, García J, Mur A, Fortuny-Guasch C and López-Botet M.

    Dynamics of the NK-cell subset redistribution induced by cytomegalovirus infection in preterm infants

    HUMAN IMMUNOLOGY . 76(2-3): 118-123. Nº de cites: 17

    [doi:10.1016/j.humimm.2015.01.017]

  • Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M and Efavirenz, Obesity Project Team on behalf of Collaboration of Observational HIV.

    Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults

    Aids . 29(2): 193-200. Nº de cites: 13

    [doi:10.1097/QAD.0000000000000530]

  • Morén C, Noguera-Julián A, Garrabou G, Rovira N, Catalán M, Bañó M, Guitart-Mampel M, Tobías E, Hernández S, Cardellach F, Miró O and Fortuny-Guasch C.

    Mitochondrial disturbances in HIV pregnancies

    Aids . 29(1): 5-12. Nº de cites: 23

    [doi:10.1097/QAD.0000000000000486]

  • Guix Comellas EM, Force Sanmartín E, Rozas L and Noguera-Julián A.

    [THE IMPORTANCE OF PROPER ADHERENCE TO ANTI-TUBERCULOSIS TREATMENT].

    Revista de enfermeria (Barcelona, Spain) . 38(1): 8-15. Nº de cites: 1

  • Lodi S, Dray-Spira R, Touloumi G, Braun D, Teira R, D'Arminio Monforte A, Gallois A, Zangerle R, Spire B, Dabis F, Stähelin C, Termote M, Kirk O, Chêne G, Egger M and del Amo J.

    Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord

    Aids . 28(15): 2297-2306. Nº de cites: 40

    [doi:10.1097/QAD.0000000000000410]

  • Flynn P, Komar S, Blanche S, Giaquinto C, Noguera-Julián A, Welch S, Lathouwers E, Van de Casteele T, Kakuda TN and Opsomer M.

    Efficacy and Safety of Darunavir/Ritonavir at 48 Weeks in Treatment-naive, HIV-1-infected Adolescents Results From a Phase 2 Open-label Trial (DIONE)

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 33(9): 940-945. Nº de cites: 22

    [doi:10.1097/INF.0000000000000308]

  • Deyà-Martinez A, Noguera-Julián A, Vila J, Vila A, Valls-Lafon A, Sánchez E, Jiménez R and Fortuny-Guasch C.

    The role of albuminuria in the follow-up of HIV-infected pediatric patients

    PEDIATRIC NEPHROLOGY . 29(9): 1561-1566. Nº de cites: 5

    [doi:10.1007/s00467-014-2814-7]

  • Madrid L, Noguera-Julián A, Falcon-Neyra L, Fortuny-Guasch C, De Felipe B, Torrebadell-Burriel M, Sanchez B, Valls-Lafon A, López-Cortès L, Benmarzouk-Hidalgo OJ and Neth O.

    Microbial translocation and T cell activation are not associated in chronic HIV-infected children

    Aids . 28(13): 1989-1992. Nº de cites: 5

    [doi:10.1097/QAD.0000000000000375]